Cargando…

CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation

This manuscript has not been published before and is not currently being considered for publication elsewhere. Increased septal convexity of left ventricle has been described in subjects with hypertrophic cardiomyopathy (HCM) -causing mutations without left ventricular hypertrophy (LVH). Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarkiainen, Mika, Sipola, Petri, Jalanko, Mikko, Heliö, Tiina, Jääskeläinen, Pertti, Kivelä, Kati, Laine, Mika, Lauerma, Kirsi, Kuusisto, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459818/ https://www.ncbi.nlm.nih.gov/pubmed/30976029 http://dx.doi.org/10.1038/s41598-019-42376-7

Ejemplares similares

The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy
por: Jørgenrud, Benedicte, et al.
Publicado: (2015)

Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy
por: Tarkiainen, Mika, et al.
Publicado: (2016)

Rotation and torsion of the left ventricle with cardiovascular magnetic resonance tagging: comparison of two analysis methods
por: Lehmonen, Lauri, et al.
Publicado: (2020)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

Myocardial fibrosis comparison by cmr between genetically positive HCM patients with MYBPC3 and MYH7 gene mutations
por: Villanueva, Alejandra, et al.
Publicado: (2015)

Correction to Lancet Neurol 2018; 17: 1061–82
Publicado: (2021)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3
por: Aurensanz Clemente, Esther, et al.
Publicado: (2017)

Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
por: Suay-Corredera, Carmen, et al.
Publicado: (2021)

Cine acquisition strategies for visualizing atrial septal defects by CMR
por: Natarajan, Arun, et al.
Publicado: (2013)

Is MYBPC3 linked to bicuspid aortic valve?
por: Niaz, Talha, et al.
Publicado: (2021)

M10.6.1: Design and manufacturing of the carrier board prototypes.
por: Jezynski, T
Publicado: (2010)

Autosomal Recessive Transmission of MYBPC3 Mutation Results in Malignant Phenotype of Hypertrophic Cardiomyopathy
por: Wang, Yilu, et al.
Publicado: (2013)

Fatal neonatal hypertrophic cardiomyopathy caused by compound heterozygous truncating MYBPC3 mutation
por: Alsters, S., et al.
Publicado: (2019)

Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy
por: Jääskeläinen, Pertti, et al.
Publicado: (2019)

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies
por: Rani, Deepa Selvi, et al.
Publicado: (2023)

1061 The Role of CD4 T Cell Mediated Immunity in Pandemic Influenza Protection
por: Nayak, Jennifer, et al.
Publicado: (2014)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2017)

Reevaluation of the South Asian MYBPC3(Δ25bp) Intronic Deletion in Hypertrophic Cardiomyopathy
por: Harper, Andrew R., et al.
Publicado: (2020)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Helms, Adam S., et al.
Publicado: (2020)

Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree
por: Torrado, Mario, et al.
Publicado: (2022)

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
por: Jansen, Mark, et al.
Publicado: (2023)

Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling
por: Farrell, Emily, et al.
Publicado: (2018)

Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction – a prospective CMR study
por: Pöyhönen, Pauli, et al.
Publicado: (2018)

1061. Clinical Phage Microbiology: Evaluating Phages for Biofilm-associated Prosthetic Valve Endocarditis
por: Gelman, Daniel, et al.
Publicado: (2021)

Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation
por: Lynch, Thomas L., et al.
Publicado: (2015)

MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma
por: Chen, Zihang, et al.
Publicado: (2021)

MYBPC1 is a key regulator for laryngeal carcinoma formation
por: Liu, Jing, et al.
Publicado: (2022)

Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?
por: Barefield, David Y.
Publicado: (2023)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
por: Mearini, Giulia, et al.
Publicado: (2013)

Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
por: Caiazza, Martina, et al.
Publicado: (2020)

Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain
por: Fernández Suárez, Natalia, et al.
Publicado: (2023)

A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy
por: Ni, Erru, et al.
Publicado: (2023)

Analysis of the septal curvature with CMR in the paediatric population with pulmonary hypertension is a useful tool
por: Pandya, Bejal, et al.
Publicado: (2012)

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy
por: Holmström, Miia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9nbfrt6delcun9i3m9nu0g12lv